We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Chicken Antibodies Guide Cancer-Killing Nanotubes

By LabMedica International staff writers
Posted on 18 Dec 2009
Print article
A recent paper described a novel hi-tech mechanism for tracking and destroying cancer cells. The method is based on a highly specific chicken antibody (immunoglobulin Y, or IgY) directed at the cancer cell surface HER2 (human epidermal growth factor receptor 2) protein covalently bound to single-walled nanotubes.

The nanotubes (SWNTs) exhibit two unique optical properties that make them useful for this application. When exposed to laser light at a wavelength of 785 nanometers, a strong Raman signal is given off that can be detected with a special Raman microscope. Exposure to laser light at 808 nanometers (near infrared or NIR) causes the SWNTs to heat up, which results in thermal destruction of living tissue in the near vicinity.

Investigators at the [U.S.] National Institute of Standards and Technology (Gaithersburg, MD, USA) worked with two types of cancer cells growing in tissue culture. Both HER2-expressing SK-BR-3 cells and HER2-negative MCF-7 cells were treated with the IgY-SWNTs and then exposed to different wavelengths of laser light.

Results published in the October 2, 2009, issue of the journal BMC Cancer revealed that the anti-HER2 IgY guided the nanotubes to those cells expressing HER2. Thus, the Raman signal collected at single-cell level from the SWNT-treated SK-BR-3 cells was significantly greater than that from the MCF-7 cells. Exposure to NIR irradiation selectively destroyed the SWNT-targeted breast cancer cells without harming receptor-free cells. Significantly, cell death was effectuated without the need of internalization of SWNTs by the cancer cells.

The authors concluded that, "The complex can be potentially used for both detection and selective photothermal ablation of receptor-positive breast cancer cells without the need of internalization by the cells. Thus, the unique intrinsic properties of SWNTs combined with high specificity and sensitivity of IgY antibodies can lead to new strategies for cancer detection and therapy."

Related Links:
[U.S.] National Institute of Standards and Technology

New
Gold Member
LEISHMANIA Test
LEISHMANIA ELISA
New
Gold Member
Chagas Disease Test
CHAGAS Cassette
New
FAP Immunoassay
Quantikine QuicKit Human FAP ELISA
New
Urine Control
MassCheck Amino Acid Analysis Urine Controls

Print article

Channels

Molecular Diagnostics

view channel
Image: A coronal MRI section shows a high-intensity focused ultrasound lesion in the left thalamus of the brain (Photo courtesy of UT Southwestern Medical Center)

Newly Identified Stroke Biomarkers Pave Way for Blood Tests to Quickly Diagnose Brain Injuries

Each year, nearly 800,000 individuals in the U.S. experience a stroke, which occurs when blood flow to specific areas of the brain is insufficient, causing brain cells to die due to a lack of oxygen.... Read more

Immunology

view channel
Image: The discovery of biomarkers could improve endometrial cancer treatment (Photo courtesy of Mount Sinai)

Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer

Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read more

Pathology

view channel
Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.